EMEA-000876-PIP07-15

  • Email
  • Help

Overview

Product details for Soliris
Invented nameSoliris
Active substance

Eculizumab

Decision numberP/0229/2016
PIP numberEMEA-000876-PIP07-15
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Prevention of delayed graft function after solid organ transplantation

Route(s) of administrationIntravenous use
PIP applicant

Alexion Europe SAS
France
Tel. +33 147100606
Fax +33 1471006 11
Email: pip.enquiries@alxn.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related information